Healthcare Services

DNA Testing Market Forecast (2026–2030): Expansion Trends

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The DNA Testing Market During The Forecast Period?

The dna testing market has observed rapid expansion in recent years. Its valuation is set to climb from $20.04 billion in 2025 to $22.4 billion in 2026, growing at a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this historical growth include advancements in molecular diagnostics, an increased demand for infectious disease testing, greater adoption of cancer screening, the growth of laboratory automation, and enhanced funding for genetic research.

The dna testing market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach $32.71 billion, demonstrating a compound annual growth rate (CAGR) of 9.9%. This projected growth stems from several factors, including the integration of precision medicine, AI-driven genetic interpretation, the emergence of population screening programs, the broader expansion of clinical genomics, and enhanced regulatory support for molecular diagnostics. Key trends foreseen during this period involve the broader application of dna testing within clinical diagnostics, its increasing utility in prenatal and newborn screening, greater uptake in oncology and pharmacogenomics, the incorporation of automated testing platforms, and a surging need for customized genetic insights.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

What Key Factors Are Shaping The DNA Testing Market Landscape?

The increasing prevalence of genetic disorders is poised to propel the growth of the DNA testing market moving forward. These medical conditions arise from abnormalities in an individual’s DNA, leading to physical, developmental, or functional impairments. The rising incidence of genetic disorders is fueled by expanded genetic screening, improved diagnostic capabilities, heightened public awareness, and the continued practice of consanguineous marriages in certain populations. The DNA testing market supports this demand by enabling early and accurate diagnosis, prognosis assessment, personalized treatment planning, and informed family-planning decisions based on an individual’s genetic profile. For instance, in February 2023, according to the World Health Organization (WHO), congenital diseases caused an estimated 240,000 newborn deaths globally within the first 28 days of life each year, and according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome annually in the United States, representing 1 in every 700 births. Therefore, the increasing prevalence of genetic disorders is driving the growth of the DNA testing market.

Which Segment Categories Are Included In The DNA Testing Market Segment Analysis?

The dna testing market covered in this report is segmented –

1) By Product Type: Equipment, Consumables, Software And Services

2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis

3) By Application: Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications

Subsegments:

1) By Equipment: PCR (Polymerase Chain Reaction) Machines, Sequencing Instruments, Microarray Systems, Electrophoresis Equipment

2) By Consumables: PCR Reagents, Sequencing Reagents, Hybridization Reagents, Enzymes And Buffers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Services, Consulting And Technical Support

What Market Trends Are Affecting The DNA Testing Market?

Major companies in the DNA testing market are primarily focused on developing advanced testing solutions, including precancer detection DNA tests, to improve early diagnosis, enable timely intervention, and enhance patient outcomes in cancer care. Precancer detection DNA tests are molecular diagnostic assays designed to identify early genetic or epigenetic alterations, such as mutations or methylation patterns, associated with the initial stages of cancer development, thereby allowing clinicians to detect the disease before symptoms emerge. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company specializing in esophageal cancer prevention diagnostics, introduced EsoGuard 2.0, a next-generation esophageal DNA test that provides improved assay performance and reduced costs through advanced molecular techniques and a higher DNA yield. Utilizing the EsoCheck Cell Collection Device, the test analyzes esophageal cell DNA via bisulfite conversion, PCR amplification, and next-generation sequencing to identify gene-specific methylation changes linked to esophageal precancer and cancer, offering clinicians a powerful tool for early detection and cancer prevention.

Who Are The Active Companies Shaping The DNA Testing Market?

Major companies operating in the dna testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics

Get The Full DNA Testing Market Report:

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Which Region Is The Largest In The DNA Testing Market?

North America was the largest region in the DNA testing market in 2025. The regions covered in the dna testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized DNA Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Browse Through More Reports Similar to the Global DNA Testing Market 2026, By The Business Research Company

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Dna Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report

Dna Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795